Tonix Pharmaceuticals Statistics
NASDAQ: TNXPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.55-0.145 (-1.88%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 7.51 -0.53%
Tonix Pharmaceuticals by the numbers
Tonix Pharmaceuticals has a market capitalization of $129.5 million based on 17.15M shares outstanding. With trailing EPS of $-13.06, Tonix Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 34.7% below its 50-day average and 43.6% below its 200-day average.
Average daily trading volume is 537.24K shares, or about $4.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TNXP valuation vs. peer median
| Metric | TNXP | Peer median | Difference |
|---|---|---|---|
| Market cap | $129.49M | $126.89M | +2% |
| Avg. volume | 537.24K | 254.40K | +111% |
Peer median across 8 companies: CLLS, RNA, SPRB, HURA, OGI, NRXP, BGM, FHTX.
Valuation
- Market cap
- $129.49M
- EPS (TTM)
- $-13.06
- Shares outstanding
- 17.15M
Price and trading
- Previous close
- 7.70
- Open
- 7.70
- Day range
- 7.42 – 7.79
- 52-week range
- 7.42 – 23.25
- 52-week change
- -67.17%
- Beta
- —
- Volume
- 703.26K
- Average volume
- 537.24K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 10, 2026
Additional statistics
- Market Cap
- 129.49M
- Forward Pe
- -0.96
- Eps
- -13.06
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 23.25
- Week52 Low
- 7.42
- Avg Volume
- 537.24K
- Shares Outstanding
- 17.15M
- Ma50
- 11.56
- Ma200
- 13.39
- Earnings Date
- Aug 10, 2026
- Pct From52w High
- -67.53%
- Pct From52w Low
- 1.75%